MedPath

Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

Not Applicable
Completed
Conditions
Dysmenorrhea
Interventions
Device: Nanoone Woman Underwear
Registration Number
NCT01449305
Lead Sponsor
Chen Yi Enterprise, Co., Ltd.
Brief Summary

To evaluate the mean change in menstrual pain intensity during menstrual cycles from baseline after wearing Nanoone Woman Underwear in women with primary dysmenorrhea

Detailed Description

The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS, ranging from zero (no pain) to ten (very severe pain). Subjects will be asked to use the VAS scoring system to record, on a provided sheet, their experienced menstrual pain level daily during menstrual bleeding for a total of three consecutive menstrual cycles.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
44
Inclusion Criteria
  1. Females aged below 40 years old.

  2. Screened by inquiry and diagnosed as primary dysmenorrhea by gynaecologist with pelvic ultrasonography.

  3. Female subject who is:

    • using adequate contraception since last menstruation and no plan for conception during the study.
    • non-lactating.
    • has negative pregnancy test (urine) within 14 days prior to the study.
  4. Informed consent form signed.

Exclusion Criteria
  1. Sensitivity to study product.
  2. Patient has been diagnosed with secondary dysmenorrhea (defined as identifiable pelvic pathology).
  3. Patient has clinically significant physical disability or abnormal findings on physical examination or laboratory testing judged by the investigator or co-investigator.
  4. Participation of any clinical investigation during the last 30 days.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Nanoone Woman UnderwearNanoone Woman Underwear"Nanoone" negative ion of textiles, which is health material specifically designed for human body, in short distance and long time to produce negative ion, the human body really needed, it can neutralize free radical in the human body.
Primary Outcome Measures
NameTimeMethod
The Mean Change in Maximum Pain Level at Each Menstrual Cycle From Baselinebaseline, first menstrual cycle, second menstrual cycle and third menstrual cycle

The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS, ranging from zero (no pain) to ten (very severe pain).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PingTung Christian Hospital

🇨🇳

Pingtung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath